Kaynaklar:
1- Aulton, M.E., Taylor K.M.G. (2007), Aulton’s Pharmaceutics: The Design and Manufacture of Medicines, Third edition, Elsevier Ltd.
2- Acartürk, F., Ağabeyoğlu, İ., Çelebi, N., Değim, T., Değim, Z., Doğanay, T., Takka, S., Tırnaksız, F.
(2007), Modern Farmasötik Teknoloji, Türk Eczacıları Birliği Eczacılık Akademisi Yayını, Ankara.
3- Gibson, M. (2004), Pharmaceutical Preformulation and Formulation, Informa Healtcare USA.
4- Guidance Document for Process Validation: General Principles and Practices, United States Food &
Drug Administration (FDA), 2011.
5-Guideline on process validation for finished products -information and data to be provided in regulatory submissions, European Medicines Agency (EMA), 2016.
6-European Medicines Agency practical guidance on the application form for centralised type IA and IB variations, European Medicines Agency (EMA), 2017.
7-Nanoscale Fabrication, Optimization, Scale-up and Biological Aspects of Pharmaceutical
Nanotechnology; Editor: Alexandru Mihai Grumezescu, William Andrew, 2017, ISBN: 0128136308, 9780128136300
8- T.C. Sağlık Bakanlığı Türkiye İlaç ve Tıbbi Cihaz Kurumu, https://www.titck.gov.tr.
